substance p has been researched along with aspirin in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (18.52) | 18.7374 |
| 1990's | 13 (48.15) | 18.2507 |
| 2000's | 5 (18.52) | 29.6817 |
| 2010's | 1 (3.70) | 24.3611 |
| 2020's | 3 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Inoki, R | 1 |
| Awaya, S; Kumazawa, T; Mizumura, K; Yokoyama, K | 1 |
| Kawakami, M; Kodama, N; Toda, N | 1 |
| Fennessy, MR; Stewart, AG; Thompson, DC | 1 |
| Fasmer, OB; Hole, K; Hunskaar, S | 1 |
| Kumazawa, T; Mizumura, K; Sato, J | 1 |
| Garcia Leme, J; Hamamura, L | 1 |
| Singh, I | 1 |
| Locatelli, L; Panerai, AE; Sacerdote, P | 1 |
| Botte, V; Di Fiore, MM; Gobbetti, A; Zerani, M | 1 |
| Kaya, H; Ohkubo, T; Shibata, M; Takahashi, H; Yamada, Y | 1 |
| Herold, M; Kähler, CM; Reinisch, N; Wiedermann, CJ | 1 |
| Bina, S; Jing, M; Ledvina, MA; Muldoon, SM; Panico, FG; Panico, JL | 1 |
| Ciccarelli, A; de Crescenzo, G; de Paulis, A; Marinò, D; Marinò, I; Marone, G | 1 |
| Calixto, JB; Cechinel Filho, V; de Campos, RO; Delle Monache, F; Pinheiro, TR; Pizzolatti, MG; Santos, AR; Vaz, ZR; Yunes, RA | 1 |
| Andrews, NP; Husain, S; Mulcahy, D; Panza, JA; Quyyumi, AA | 1 |
| Quyyumi, AA | 1 |
| Buckingham, JC; Kennard, C; Rhodes, KF | 1 |
| Aubel, B; Ballet, S; Bourgoin, AS; Cesselin, F; Farré, A; Hamon, M; Mauborgne, A; Poliénor, H | 1 |
| Choi, SS; Lee, JK; Suh, HW | 1 |
| Davie, AP; McMurray, JJ | 1 |
| Berkels, R; Grosser, N; Gründemann, D; Schömig, E; Schröder, H; Taubert, D | 1 |
| Hibi, S; Ishii, M; Kume, H; Ouchi, Y; Teramoto, S; Yamaguchi, Y; Yamamoto, H | 1 |
| Całka, J; Gańko, M | 1 |
| Całka, J; Rytel, L | 1 |
| Barragan, AA; Bas, S; Bauman, LM; Coetzee, JF; Gonzalez, JDR; Lakritz, J; Menichetti, B; Piñeiro, JM; Schuenemann, GM; Velez, J | 1 |
| Cvetković, G; Gaćeša, D; Perić, A; Vojvodić, D | 1 |
2 review(s) available for substance p and aspirin
| Article | Year |
|---|---|
[Site of action of analgesics: the peripheral site of action of these drugs].
Topics: Analgesics; Animals; Aspirin; Bradykinin; Endorphins; Feedback; Humans; Narcotics; Neurons, Afferent; Neurotransmitter Agents; Nociceptors; Substance P | 1990 |
Effects of aspirin on endothelial dysfunction in atherosclerosis.
Topics: Acetylcholine; Animals; Arteriosclerosis; Aspirin; Drug Interactions; Endothelium, Vascular; Humans; Nitroprusside; Platelet Aggregation Inhibitors; Substance P; Vascular Resistance; Vasodilator Agents | 1998 |
3 trial(s) available for substance p and aspirin
| Article | Year |
|---|---|
Aspirin improves endothelial dysfunction in atherosclerosis.
Topics: Acetylcholine; Arteriosclerosis; Aspirin; Blood Pressure; Cyclooxygenase Inhibitors; Endothelium, Vascular; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Nitroprusside; Reproducibility of Results; Substance P; Vasodilation; Vasodilator Agents | 1998 |
Antiplatelet cilostazol, an inhibitor of type III phosphodiesterase, improves swallowing function in patients with a history of stroke.
Topics: Aged; Aspirin; Cilostazol; Cross-Over Studies; Deglutition Disorders; Double-Blind Method; Humans; Male; Phosphodiesterase Inhibitors; Saliva; Stroke; Substance P; Tetrazoles | 2008 |
Administration of acetylsalicylic acid after parturition in lactating dairy cows under certified organic management: Part II. Biomarkers of nociception, inflammation, and stress.
Topics: Animals; Aspirin; Biomarkers; Cattle; Cattle Diseases; Dystocia; Female; Haptoglobins; Hydrocortisone; Inflammation; Lactation; Milk; Nociception; Parity; Parturition; Pregnancy; Substance P | 2020 |
22 other study(ies) available for substance p and aspirin
| Article | Year |
|---|---|
Implication of polymodal receptor activities in intraocular pressure elevation by neurogenic inflammation.
Topics: Animals; Anterior Chamber; Aspirin; Bradykinin; Female; Glucose; Intraocular Pressure; Male; Neuritis; Procaine; Rabbits; Receptors, Cell Surface; Receptors, Drug; Sodium Chloride; Substance P; Tachyphylaxis | 1990 |
Suppression of the cerebral vasospastic actions of oxyhemoglobin by ascorbic acid.
Topics: Animals; Ascorbic Acid; Aspirin; Basilar Artery; Cattle; Cerebral Arteries; Dogs; Female; Ischemic Attack, Transient; Macaca; Male; Nicotine; Nitroglycerin; Oxyhemoglobins; Potassium Chloride; Substance P; Time Factors; Vasoconstriction | 1991 |
Modulation of substance P-induced bronchoconstriction by lipoxygenase metabolites.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; 5,8,11,14-Eicosatetraynoic Acid; Airway Resistance; Anesthesia; Animals; Anti-Inflammatory Agents; Aspirin; Bronchi; Female; Guinea Pigs; In Vitro Techniques; Indomethacin; Lipoxygenase; Male; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Substance P | 1985 |
Acetylsalicylic acid, paracetamol and morphine inhibit behavioral responses to intrathecally administered substance P or capsaicin.
Topics: Acetaminophen; Animals; Aspirin; Behavior, Animal; Capsaicin; Dose-Response Relationship, Drug; Injections, Spinal; Male; Mice; Morphine; Pain; Substance P | 1985 |
Effects of prostaglandins and other putative chemical intermediaries on the activity of canine testicular polymodal receptors studied in vitro.
Topics: Animals; Aspirin; Bradykinin; Dinoprostone; Dogs; Epoprostenol; In Vitro Techniques; Male; Nociceptors; Prostaglandins; Prostaglandins E; Saline Solution, Hypertonic; Serotonin; Substance P; Testis | 1987 |
Formation of a factor increasing vascular permeability during electrical stimulation of the saphenous nerve in rats.
Topics: Acetylcholine; Animals; Aspirin; Bradykinin; Capillary Permeability; Carboxypeptidases; Chymotrypsin; Dialysis; Electric Stimulation; Histamine; Indomethacin; Kininogens; Kinins; Leg; Male; Neurons; Perfusion; Prostaglandins; Proteins; Rats; Serotonin; Staining and Labeling; Substance P; Trypsin | 1974 |
Release of a bradykinin-like substance of nervous stimulation of a frog stomach muscle preparation.
Topics: Animals; Anura; Aspirin; Bradykinin; Intestine, Small; Muscle Contraction; Muscle, Smooth; Peptides; Rabbits; Stomach; Substance P; Vagus Nerve | 1967 |
Inhibitory effect of NSAIDs on the chemotaxis induced by substance P on human monocytes and polymorphonuclear cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Chemotaxis, Leukocyte; Diclofenac; Humans; Ibuprofen; Indomethacin; Leukocytes; Monocytes; Neutrophils; Piroxicam; Substance P | 1993 |
Relationships among GnRH, substance P, prostaglandins, sex steroids and aromatase activity in the brain of the male lizard Podarcis sicula sicula during reproduction.
Topics: Androgens; Animals; Aromatase; Aspirin; Brain; Dinoprost; Dinoprostone; Estradiol; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Lizards; Male; Organ Culture Techniques; Progesterone; Prostaglandins; Reproduction; Substance P | 1994 |
Role of substance P in neurogenic inflammation in the rat incisor pulp and the lower lip.
Topics: Animals; Aspirin; Atropine; Bradykinin; Capillary Permeability; Cheilitis; Dental Pulp; Electric Stimulation; Histamine; Histamine Release; Incisor; Lip; Male; Mandibular Nerve; Methysergide; p-Methoxy-N-methylphenethylamine; Phentolamine; Propranolol; Pulpitis; Pyrilamine; Rats; Rats, Wistar; Substance P | 1993 |
Interaction of substance P with epidermal growth factor and fibroblast growth factor in cyclooxygenase-dependent proliferation of human skin fibroblasts.
Topics: Animals; Arachidonic Acid; Aspirin; Cattle; Cell Division; Cells, Cultured; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Epidermal Growth Factor; Fibroblast Growth Factors; Fibroblasts; Humans; Leukotriene B4; Prostaglandin-Endoperoxide Synthases; Skin; Substance P | 1996 |
Diaspirin cross-linked hemoglobin does not alter isolated human umbilical artery or vein tone.
Topics: Acetylcholine; Animals; Aspirin; Cyclic GMP; Dose-Response Relationship, Drug; Hemoglobins; Humans; Muscle Tonus; Muscle, Smooth, Vascular; Nitric Oxide; Nitroglycerin; Serotonin; Substance P; Swine; Umbilical Arteries; Umbilical Veins; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 1996 |
Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs.
Topics: Adenosine; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chymases; Cyclosporine; Diclofenac; Histamine Release; Humans; Immunoglobulin E; Immunosuppressive Agents; Leukotriene C4; Mast Cells; Methotrexate; Middle Aged; Polyenes; Prostaglandins D; Rheumatic Diseases; Serine Endopeptidases; Sirolimus; Substance P; Sulfonamides; Synovial Membrane; Tacrolimus; Tryptases | 1997 |
Antinociceptive properties of the hydroalcoholic extract and preliminary study of a xanthone isolated from Polygala cyparissias (Polygalaceae).
Topics: Abdominal Pain; Acetic Acid; Analgesia; Analgesics; Animals; Aspirin; Bradykinin; Capsaicin; Ethanol; Hot Temperature; Male; Pain; Pain Measurement; Plant Extracts; Plants, Medicinal; Rats; Rats, Wistar; Substance P; Water; Xanthenes; Xanthones | 1997 |
The inhibition of nicotine-evoked relaxation of the guinea-pig isolated basilar artery by some analgesic drugs and progesterone.
Topics: Analgesics; Animals; Aspirin; Basilar Artery; Capsaicin; Dinoprost; Guinea Pigs; In Vitro Techniques; Indomethacin; Male; Migraine Disorders; NG-Nitroarginine Methyl Ester; Nicotine; Progesterone; Substance P; Sumatriptan; Vasodilation | 1999 |
The novel analgesic, cizolirtine, inhibits the spinal release of substance P and CGRP in rats.
Topics: Acetic Acid; Analgesics; Anesthesia; Anesthetics, Inhalation; Animals; Aspirin; Calcitonin Gene-Related Peptide; Dose-Response Relationship, Drug; Halothane; In Vitro Techniques; Injections, Intraperitoneal; Injections, Spinal; Male; Pain; Potassium; Pyrazoles; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance P | 2001 |
Antinociceptive profiles of aspirin and acetaminophen in formalin, substance P and glutamate pain models.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Aspirin; Behavior, Animal; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Foot; Glutamic Acid; Male; Mice; Mice, Inbred ICR; Nociceptors; Pain; Pain Measurement; Receptors, Glutamate; Receptors, Neurokinin-1; Spinal Cord; Substance P; Synaptic Transmission | 2001 |
Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor.
Topics: Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Bradykinin; Confidence Intervals; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Female; Heart Failure; Humans; Male; Middle Aged; Substance P; Vasodilation | 2002 |
Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Aspirin; Cells, Cultured; Chelating Agents; Citrulline; Coronary Vessels; Egtazic Acid; Endothelium, Vascular; Free Radical Scavengers; Homeostasis; Humans; In Vitro Techniques; Nitric Oxide; Oxidants; Substance P; Superoxides; Swine | 2004 |
Prolonged acetylsalicylic-acid-supplementation-induced gastritis affects the chemical coding of the stomach innervating vagal efferent neurons in the porcine dorsal motor vagal nucleus (DMX).
Topics: Acetyltransferases; Animals; Aspirin; Enkephalin, Leucine; Galanin; Gastric Mucosa; Gastritis; Medulla Oblongata; Nerve Tissue Proteins; Neurons, Efferent; Nitric Oxide Synthase Type I; Pituitary Adenylate Cyclase-Activating Polypeptide; Stomach; Substance P; Swine; Vagus Nerve; Vasoactive Intestinal Peptide | 2014 |
Aspirin Administration Affects Neurochemical Characterization of Substance P-Like Immunoreactive (SP-LI) Nodose Ganglia Neurons Supplying the Porcine Stomach.
Topics: Animals; Aspirin; Female; Neuropeptides; Nodose Ganglion; Stomach; Substance P; Swine | 2020 |
Inflammatory mediators in nasal secretions of patients with nasal polyposis with and without aspirin sensitivity.
Topics: Aspirin; Asthma, Aspirin-Induced; Cross-Sectional Studies; Humans; Inflammation Mediators; Nasal Polyps; Rhinitis; Sinusitis; Substance P; Tryptases | 2023 |